Omnicell's (OMCL) Central Pharmacy Dispensing Service Selected by Tucson VA Medical Center
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- US futures fall on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Omnicell (OMCL) PT Raised to $155 at Cantor Fitzgerald
November 2, 2021 11:38 AM EDTCantor Fitzgerald analyst Steven Halper raised the price target on Omnicell (NASDAQ: OMCL) to $155.00 (from $135.00) while maintaining a Neutral rating.
The analyst commented, "We reiterate our Neutral rating on OMCL shares but increase our 12-month, DCF-based price target to $155 (compared to $135 previously). This morning, November 2, the company reported 3Q21 results that were ahead of our estimates and FactSet consensus. Revenue was $296 million compared to our estimate of $284 million. Revenue... More
Omnicell (OMCL) Tops Q3 EPS by 17c
November 2, 2021 7:35 AM EDTOmnicell (NASDAQ: OMCL) reported Q3 EPS of $1.08, $0.17 better than the analyst estimate of $0.91. Revenue for the quarter came in at $296 million versus the consensus estimate of $284.74 million.
GUIDANCE:
Omnicell sees FY2021 EPS of $3.80-$3.85, versus the consensus of $3.73. Omnicell sees... More
